ArticleCancer science2022
Establishment of a deep-learning system to diagnose BI-RADS4a or higher using breast ultrasound for clinical application.
Article in Cancer science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Robotic breast ultrasound with knowledge-guided path planning and vision feedback.Journal of ultrasound · 2026Article
- Toward a Structured Imaging Reporting System for Kidney Masses: The Molecular Imaging Perspective on KI-RADS.Molecular imaging and biology · 2026Review
- An interpretable ultrasound-based deep learning system for early breast cancer in a Chinese population.Insights into imaging · 2026Article
- Evaluation of AI diagnostic systems for breast ultrasound: comparative analysis with radiologists and the effect of AI assistance.Japanese journal of radiology · 2025Article
- Optimizing Artificial Intelligence Thresholds for Mammographic Lesion Detection: A Retrospective Study on Diagnostic Performance and Radiologist-Artificial Intelligence Discordance.Diagnostics (Basel, Switzerland) · 2025Article
- Ultrasound-based deep learning radiomics for multi-stage assisted diagnosis in reducing unnecessary biopsies of BI-RADS 4A lesions.Quantitative imaging in medicine and surgery · 2025Article
- Clinical Application of Artificial Intelligence in Ultrasound Imaging for Oncology.JMA journal · 2025Review
- Review
- Deep learning method for detecting fluorescence spots in cancer diagnostics via fluorescence in situ hybridization.Scientific reports · 2024Article
- Transfer learning classification of suspicious lesions on breast ultrasound: is there room to avoid biopsies of benign lesions?European radiology experimental · 2024Article
- Use of a commercial artificial intelligence-based mammography analysis software for improving breast ultrasound interpretations.European radiology · 2024Article
- Use of ultrasound imaging Omics in predicting molecular typing and assessing the risk of postoperative recurrence in breast cancer.BMC women's health · 2024Article
- A validation of an entropy-based artificial intelligence for ultrasound data in breast tumors.BMC medical informatics and decision making · 2024Article
- Artificial Intelligence in Breast Ultrasound: From Diagnosis to Prognosis-A Rapid Review.Diagnostics (Basel, Switzerland) · 2022Review
- Establishment of a deep-learning system to diagnose BI-RADS4a or higher using breast ultrasound for clinical application.Cancer science · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
Although the categorization of ultrasound using the Breast Imaging Reporting and Data System (BI-RADS) has become widespread worldwide, the problem of inter-observer variability remains. To maintain uniformity in diagnostic accuracy, we have developed a system in which artificial intelligence (AI) can distinguish whether a static image obtained using a breast ultrasound represents BI-RADS3 or lower or BI-RADS4a or higher to determine the medical management that should be performed on a patient whose breast ultrasound shows abnormalities. To establish and validate the AI system, a training dataset consisting of 4028 images containing 5014 lesions and a test dataset consisting of 3166 images containing 3656 lesions were collected and annotated. We selected a setting that maximized the area under the curve (AUC) and minimized the difference in sensitivity and specificity by adjusting the internal parameters of the AI system, achieving an AUC, sensitivity, and specificity of 0.95, 91.2%, and 90.7%, respectively. Furthermore, based on 30 images extracted from the test data, the diagnostic accuracy of 20 clinicians and the AI system was compared, and the AI system was found to be significantly superior to the clinicians (McNemar test, p < 0.001). Although deep-learning methods to categorize benign and malignant tumors using breast ultrasound have been extensively reported, our work represents the first attempt to establish an AI system to classify BI-RADS3 or lower and BI-RADS4a or higher successfully, providing important implications for clinical actions. These results suggest that the AI diagnostic system is sufficient to proceed to the next stage of clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.